ESG Report 2020

On 2 September 2020, Mr. Defu Liu, the Chief Quality Officer of The United Laboratories, presided over the special training on “ Laws, Regulations and Guides Issued by the National Medical Products Administration in the Past Two Years ” . Sales personnel and representatives from various departments participated in the training. Chief Officer Liu gave detailed explanation o n t h e d e v e l o pme n t a n d l e g a l requirements of the pharmaceutical industry in China, including the overview of regulations in the past two years, the Measures for the Administration of Drug Registration, Measures for the Supervision and Administration of Drug Production, and the Technical Guiding Principles for the Study of Pharmaceutical Changes in Listed Chemical Drugs, etc., with the Group's situation to explain the changes in requirements of quality regulations in recent years and the impact on the Group's productivity. Quality Management Training Activities The Fifth Inspection Branch of the Inner The quality management personnel of The Mongolia Autonomous Region Medical United Laboratories introduced the Group, Products Administration organised an its GMP management, fulfilment of primary exchange and learning session for 14 responsibilities, environmental protection pharmaceutical companies in Inner work, and occupational health and safety Mongolia Company, so as to enhance management to other companies. The regulation on drug manufacturers and Group led the visit to production plants, promote the growth of the pharmaceutical warehouse and laboratories, and industry. exchanged on software management and production quality management experience with personnel from other companies, so as to learn from each other and improve product quality together. Learning Exchange among Pharmaceutical Companies T h e G r o u p h a s s ummo n e d t h e management and staff to participate in the online publicity and implementation meeting on the new Pharmacopoeia organised by the Chinese Pharmacopeia Commission. Analysis on the requirements in the new Pharmacopoeia, and explanation on the amendments regarding medicines, techologies and pharmaceutic adjuvant were made during the meeting, so that the employees could clearly understand the requirements of the new Pharmacopoeia and prepare accordingly. The quality of the products could be improved to meet the increasingly stringent leg l requiremenets. a Zhuhai Company organised multiple internal training regarding the new Pharmacopoeia for employees. The scope of the traning includes the revised standards of the products, changes on the requirements on insulin and operation learning for quality management personnel. Cross-department meetings and knowledge contest on the new Pharmacopoeia were also held to enhance the understanding and application of the new Pharmacopoeia among employees. Training Activities on New Pharmacopoeia 40 Environmental, Social and Governance Report 2020 The United Laboratories International Holdings Limited